Gastritis: Clinical Trials

7 trials for Gastritis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed. 7 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 27Completed 7
Phase 31Completed 1

Follow Gastritis: new trials by email Literature Review of Gastritis trials Research Report on Gastritis

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Houtou Jianweiling Tablet in the Treatment of Chronic Non-Atrophic Gastritis
Houtou Jianweiling tablet, Omeprazole Tablet - Gastritis
Phase 2CompletedUniversity of Karachi2402022-11-082023-04-18
Efficacy and Safety of Using Granules Dendrobii for the Treatment of Chronic Atrophic Gastritis
Granules Dendrobii, Placebo - Atrophic Gastritis
Phase 2CompletedChinese University of Hong Kong202022-11-012026-07-27
Clinical Trial to Evaluate the Efficacy and Safety of CKD-495 Tablet
CKD-495 75mg, CKD-495 150mg, Artemisiae argyi folium 95% ethanol ext.(20→1) 60mg - Gastritis
Phase 2CompletedChong Kun Dang Pharmaceutical2502018-01-162018-10-31
Chemoprevention of Gastric Carcinogenesis
Eflornithine, Eflornithine placebo - Gastric Cancer, Gastric Intestinal Metaplasia
Phase 2CompletedVanderbilt-Ingram Cancer Center912016-09-192026-09-02
Residual Gastric Volume After the Ingestion of a Beverage Containing Carbohydrates Plus Whey Protein
Carbohydrate plus whey protein enriched drink - Peptic Ulcer, Gastritis
Phase 2 / Phase 3CompletedFederal University of Mato Grosso302013-02-012013-04-10
L-cysteine Prevents Stomach Exposure to Carcinogenic Acetaldehyde
Slow-release L-cysteine - Gastritis, Atrophic
Phase 2CompletedPer Hellström82012-12-012016-01-25
YF476 and Type I Gastric Carcinoids
YF476 - Chronic Atrophic Gastritis, Hypergastrinaemia
Phase 2CompletedTrio Medicines Ltd.82011-01-042019-08-19

Narrower conditions

Gastritis, Atrophic (4)  ·  Fasting (1)  ·  Peptic Ulcer (1)  ·  Stomach Neoplasms (1)

Broader conditions

Digestive System Diseases (7)  ·  Gastroenteritis (7)  ·  Gastrointestinal Diseases (7)  ·  Stomach Diseases (7)  ·  Behavior (1)  ·  Digestive System Neoplasms (1)  ·  Duodenal Diseases (1)  ·  Feeding Behavior (1)  ·  Gastrointestinal Neoplasms (1)  ·  Intestinal Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)

Interventions

Carbohydrates (1)  ·  Eflornithine (1)  ·  Medicine, Chinese Traditional (1)  ·  Omeprazole (1)  ·  YF 476 (1)  ·  rebamipide (1)

Sponsors

Chinese University of Hong Kong (1)  ·  Chong Kun Dang Pharmaceutical (1)  ·  Federal University of Mato Grosso (1)  ·  Per Hellström (1)  ·  Trio Medicines Ltd. (1)  ·  University of Karachi (1)  ·  Vanderbilt-Ingram Cancer Center (1)

Countries

Brazil (1)  ·  Honduras (1)  ·  Hong Kong (1)  ·  Pakistan (1)  ·  Puerto Rico (1)  ·  South Korea (1)  ·  Sweden (1)  ·  United Kingdom (1)

Top investigators

Doug Morgan, MD (1)  ·  Keith Wilson, MD (1)  ·  Malcolm Boyce, BSc FRCP FFPM (1)  ·  Mark Pritchard, PhD FRCP (1)  ·  Per M Hellstrom, MD, PhD (1)  ·  Zhixiu Lin, Professor (1)

Results publications

PMID 24098507, PMID 38440179, PMID 40255536, PMID 41801147

NIH funding

R01CA190612 (1)